Related Experiment Video
Updated: Sep 23, 2025

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
Published on: August 11, 2023
New-onset acute ischemic stroke following COVID-19: A case-control study
Fariborz Khorvash1, Mohammad Amin Najafi1, Mohsen Kheradmand1
1Department of Neurology, Al Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Patients with COVID-19 who experienced acute ischemic stroke were older and had more severe disease. Higher white blood cell, neutrophil, D-Dimer, and BUN levels were observed in stroke patients.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiovascular Medicine
Background:
- Neurological complications of COVID-19 are increasingly recognized.
- COVID-19 is associated with an elevated risk of thromboembolic events.
- Understanding the link between COVID-19 and acute ischemic stroke (AIS) is crucial.
Purpose of the Study:
- To compare clinical characteristics and outcomes of COVID-19 patients with and without new-onset AIS.
- To identify factors associated with AIS in COVID-19 patients.
Main Methods:
- A single-center retrospective case-control study was conducted.
- Demographics, clinical data, laboratory findings, and outcomes were compared between 51 COVID-19 patients with AIS and 160 COVID-19 patients without AIS.
Main Results:
- COVID-19 patients with AIS were older and more likely to have critical illness, ICU admission, prolonged hospitalization, and higher mortality.
- Lower oxygen saturation, PH, and HCO3 levels were noted in AIS patients at admission.
- Elevated white blood cell count, neutrophil count, neutrophil-lymphocyte ratio, D-Dimer, BUN, and BUN/Cr ratio were significantly higher in patients with AIS.
Conclusions:
- AIS in COVID-19 is multifactorial, influenced by conventional stroke risk factors and COVID-19 severity.
- Severe COVID-19 increases the risk of ischemic stroke.
- Specific laboratory markers (leukocyte, neutrophil, D-Dimer, BUN) are associated with AIS in COVID-19 patients.
Background:
Neurological manifestations of coronavirus disease 2019 (COVID-19) have been highlighted. COVID-19 potentially increases the risk of thromboembolism. We aimed to compare patients with COVID-19 with and without new-onset acute ischemic stroke (AIS).
Materials And Methods:
In this single-center retrospective case-control study, demographics, clinical characteristics, laboratory findings, and clinical outcomes were compared between 51 patients with both COVID-19 and AIS (group A) and 160 patients with COVID-19 and without AIS (group B).
Results:
Patients in group A were significantly older, more likely to present with critical COVID-19 (P = 0.004), had higher rates of admission in the intensive care unit (P < 0.001), more duration of hospitalization (P < 0.001), and higher in-hospital mortality (P < 0.001). At the time of hospitalization, O2 saturation (P = 0.011), PH (P = 0.04), and HCO3 (P = 0.005) were lower in group A. White blood cell count (P = 0.002), neutrophil count (P < 0.001), neutrophil-lymphocyte ratio (P = 0.001), D-Dimer (P < 0.001), blood urea nitrogen (BUN) (P < 0.001), and BUN/Cr ratio (P < 0.001) were significantly higher in patients with AIS.
Conclusion:
Stroke in COVID-19 is multifactorial. In addition to conventional risk factors of ischemic stroke (age and cardiovascular risk factors), we found that patients with more severe COVID-19 are more prone to ischemic stroke. Furthermore, leukocyte count, neutrophil count, neutrophil-lymphocyte ratio, D-Dimer, BUN, and BUN/Cr ratio were higher in patients with AIS following COVID-19 infection.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome IV: Interprofessional Care

